Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is an inexorably progressive lung disease of unknown origin. Prognosis is poor, with limited treatment options available, and the median survival remains just 3–5 years. Despite the use of pirfenidone and nintedanib for the treatment of IPF, curative therapies rem...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Med (Lausanne)
Main Authors: Tzouvelekis, Argyrios, Toonkel, Rebecca, Karampitsakos, Theodoros, Medapalli, Kantha, Ninou, Ioanna, Aidinis, Vasilis, Bouros, Demosthenes, Glassberg, Marilyn K.
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2018
Assuntos:
Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5962715/
https://ncbi.nlm.nih.gov/pubmed/29868594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2018.00142
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados